News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
108,890 Results
Type
Article (1901)
Company Profile (45)
Press Release (106944)
Section
Business (42252)
Career Advice (58)
Deals (6765)
Drug Delivery (4)
Drug Development (13885)
Employer Resources (5)
FDA (2130)
Job Trends (2690)
News (63102)
Policy (3700)
Tag
Academia (218)
Accelerated approval (3)
Allergies (24)
Alliances (5254)
ALS (17)
Alzheimer's disease (159)
Antibody-drug conjugate (ADC) (18)
Approvals (2213)
Artificial intelligence (38)
Autoimmune disease (3)
Automation (1)
Bankruptcy (29)
Best Places to Work (2621)
BIOSECURE Act (1)
Biosimilars (11)
Biotechnology (32)
Bladder cancer (21)
Brain cancer (5)
Breast cancer (81)
Cancer (628)
Cardiovascular disease (58)
Career advice (51)
CAR-T (15)
Cell therapy (58)
Cervical cancer (7)
Clinical research (12196)
Collaboration (125)
Compensation (119)
Complete response letters (1)
COVID-19 (319)
CRISPR (11)
C-suite (41)
Cystic fibrosis (25)
Data (907)
Depression (11)
Diabetes (73)
Diagnostics (978)
Digital health (7)
Diversity, equity & inclusion (4)
Drug discovery (16)
Drug pricing (4)
Duchenne muscular dystrophy (37)
Earnings (32752)
Employer resources (4)
Events (16255)
Executive appointments (79)
FDA (2683)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (98)
Gene editing (19)
Generative AI (2)
Gene therapy (47)
GLP-1 (118)
Government (429)
Grass and pollen (1)
Guidances (238)
Healthcare (3160)
HIV (7)
Huntington's disease (3)
IgA nephropathy (11)
Immunology and inflammation (19)
Indications (7)
Infectious disease (347)
Inflammatory bowel disease (28)
Influenza (14)
Intellectual property (13)
Interviews (9)
IPO (4776)
IRA (1)
Job creations (259)
Job search strategy (45)
Kidney cancer (4)
Labor market (5)
Layoffs (23)
Legal (544)
Liver cancer (8)
Longevity (1)
Lung cancer (93)
Lymphoma (56)
Machine learning (2)
Manufacturing (48)
MASH (28)
Medical device (2321)
Medtech (2325)
Mergers & acquisitions (2147)
Metabolic disorders (168)
Multiple sclerosis (18)
NASH (2)
Neurodegenerative disease (10)
Neuropsychiatric disorders (3)
Neuroscience (270)
NextGen: Class of 2025 (790)
Non-profit (341)
Now hiring (1)
Obesity (70)
Opinion (4)
Ovarian cancer (13)
Pain (13)
Pancreatic cancer (35)
Parkinson's disease (22)
Patents (27)
Patient recruitment (32)
Peanut (12)
People (5670)
Pharmaceutical (10)
Pharmacy benefit managers (3)
Phase I (3312)
Phase II (5184)
Phase III (4590)
Pipeline (1019)
Policy (5)
Postmarket research (451)
Preclinical (1296)
Press Release (8)
Prostate cancer (28)
Radiopharmaceuticals (39)
Rare diseases (75)
Real estate (512)
Regulatory (3167)
Reports (12)
Research institute (216)
Resumes & cover letters (3)
RSV (10)
Schizophrenia (24)
Series A (12)
Series B (8)
Service/supplier (3)
Sickle cell disease (15)
Special edition (1)
Spinal muscular atrophy (31)
Sponsored (1)
Startups (276)
Stomach cancer (3)
Supply chain (15)
Tariffs (3)
Vaccines (114)
Venture capital (4)
Weight loss (33)
Women's health (4)
Worklife (3)
Date
Today (28)
Last 7 days (90)
Last 30 days (374)
Last 365 days (6336)
2025 (4421)
2024 (7280)
2023 (8642)
2022 (10619)
2021 (11480)
2020 (10619)
2019 (7541)
2018 (5565)
2017 (5174)
2016 (3833)
2015 (5278)
2014 (3501)
2013 (2247)
2012 (2445)
2011 (2766)
2010 (2555)
Location
Africa (49)
Alabama (6)
Alaska (1)
Arizona (24)
Arkansas (1)
Asia (6086)
Australia (3349)
California (1587)
Canada (478)
China (116)
Colorado (88)
Connecticut (51)
Delaware (48)
Europe (13125)
Florida (160)
Georgia (59)
Idaho (6)
Illinois (73)
India (2)
Indiana (162)
Iowa (1)
Japan (42)
Kansas (12)
Kentucky (3)
Louisiana (7)
Maine (14)
Maryland (187)
Massachusetts (1888)
Michigan (34)
Minnesota (196)
Mississippi (1)
Missouri (32)
Montana (3)
Nebraska (1)
Nevada (10)
New Hampshire (10)
New Jersey (614)
New York (401)
North Carolina (191)
North Dakota (1)
Northern California (798)
Ohio (57)
Oklahoma (3)
Oregon (5)
Pennsylvania (360)
Puerto Rico (1)
South America (93)
South Carolina (2)
Southern California (677)
Tennessee (34)
Texas (143)
United States (6558)
Utah (69)
Virginia (15)
Washington D.C. (4)
Washington State (147)
West Virginia (1)
Wisconsin (13)
108,890 Results for "61".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
vTv Therapeutics Will Participate in INNODIA Symposium at the EASD 61st Annual Meeting
September 16, 2025
·
4 min read
Press Releases
Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting
September 11, 2025
·
4 min read
Press Releases
Reprieve Cardiovascular Secures $61 Million Financing and Enrolls First Patient in Pivotal Study
August 14, 2025
·
5 min read
Press Releases
Tendonitis Treatment Market Size to Hit USD 321.61 Billion by 2034
June 26, 2025
·
1 min read
Press Releases
Natera Announces Launch of ABCSG 61 (“TEODOR”), a Randomized Controlled Trial of Signatera™ in Early-Stage Breast Cancer
July 30, 2025
·
4 min read
Press Releases
Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update
September 16, 2025
·
8 min read
Press Releases
Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting
September 2, 2025
·
2 min read
Press Releases
Ascletis Presented Results from Cohorts 1 and 2 of 28-day Multiple Ascending Dose Study of Its Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting
September 17, 2025
·
4 min read
Press Releases
Generic Drugs Market Size to Hit USD 775.61 Billion by 2033
February 28, 2025
·
1 min read
Press Releases
Cell Expansion Market Size to Exceed USD 61.81 Billion by 2034
February 26, 2025
·
1 min read
1 of 10,889
Next
